Oak Thistle’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-69,383
Closed -$2.96M – 499
2026
Q2
$2.96M Buy
69,383
+52,467
+310% +$2.85M 0.29% 116
2026
Q1
$1.06M Buy
+16,916
New +$1.35M 0.1% 326
2025
Q4
– Sell
-48,501
Closed -$4.74M – 511
2025
Q3
$4.74M Buy
+48,501
New +$5.02M 0.72% 8
2025
Q2
– Sell
-7,359
Closed -$742K – 472
2025
Q1
$742K Buy
+7,359
New +$741K 0.15% 242
2023
Q3
– Sell
-7,962
Closed -$431K – 470
2023
Q2
$431K Buy
+7,962
New +$416K 0.23% 189
2022
Q1
– Sell
-5,698
Closed -$242K – 387
2021
Q4
$242K Buy
+5,698
New +$239K 0.19% 245

Other funds holding BSX

Oak Thistle's BSX Position: Q3 2026 in Review

Oak Thistle sold out of Boston Scientific (BSX) in Q3 2026, closing a stake of 69,383 shares — an estimated $2.96M sold.

Oak Thistle first reported a position in BSX in Q4 2021 and held it in 6 quarters. The position peaked at $4.74M in Q3 2025. 1,274 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Oak Thistle reported no remaining Boston Scientific position as of Q3 2026 after selling out during the quarter.
  • Oak Thistle sold 69,383 Boston Scientific shares in Q3 2026, an estimated $2.96M.
  • Oak Thistle first reported a position in Boston Scientific in Q4 2021 and held it in 6 quarters.
  • Oak Thistle's Boston Scientific position peaked at $4.74M in Q3 2025.
  • 1,274 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Oak Thistle's 13F filing for Q3 2026, filed 21 Oct 2026.